[Lactate dehydrogenase in ovarian carcinomas in relation to clinical and pathological findings].
D000230:Adenocarcinoma / Q000201:enzymology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004715:Endometriosis / Q000201:enzymology; D004848:Epithelium / Q000187:drug effects; D005260:Female; D006651:Histocytochemistry; D006652:Histological Techniques; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis / Q000378:metabolism*; D008593:Menopause; D009362:Neoplasm Metastasis; D009372:Neoplasms, Connective Tissue; D009852:Omentum; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology / Q000532:radiotherapy; D010053:Ovary
D003520:Cyclophosphamide; D007770:L-Lactate Dehydrogenase
Klinik und Pathologie der Lactatdehydrogenase im Ovarialcarcinom.